FDA User Fee Riders Still Undecided; MedPAC Reviews Pharmacy Fees; OMB Reviews Discarded Drug Policy

By John Wilkerson / September 26, 2022 at 3:43 PM
It’s the last week before the government shuts down, and it’s still unclear what few FDA policy riders lawmakers might include in the user fee reauthorization measure they plan to attach to the stopgap funding bill. Also this week, congressional Medicare advisers will be presented with research on concessions that pharmacy benefit managers charge pharmacies. And White House budget officials are reviewing a rule to make drug companies pay back Medicare for discarded drugs. Sens. Patty Murray (D-WA) and Richard...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.